#Semaglutide

While Mounjaro sales surged 229% to Rs 1,544 crore, Indian generic semaglutide brands have also gained ground, accounting for around 74% of monthly sales volumes in September

Scientists found that semaglutide, Ozempic’s key ingredient, repaired blood vessels, dampened inflammation and improved kidney function in patients.

Demand for Buy Semaglutide Online USA across New York keeps climbing, driven largely by word-of-mouth referrals. Every order passes a multi-point inspection — batch match, blister seal, expiry window — before it leaves the facility.…

Two recent studies have suggested that GLP-1 drugs can reduce the occurrence or severity of certain infections.

A recent trial is the latest to suggest that GLP-1s aren't just for treating diabetes and obesity.

A major new analysis suggests semaglutide (Ozempic, Wegovy) works remarkably well in adults over 65, helping many lose substantial amounts of weight while improving heart and metabolic health.…

April sales data shows indigenous obesity and diabetes drug, led by Torrent, are expanding access without denting demand for branded versions.

Men’s Health spoke to Thomas Kruse and Jesper Lau, two chemists responsible for creating the drug that’s revolutionized how we think about weight and weight-loss today.

From Independent RSS Feed: New study finds Wegovy shots have three positive effects on drinkers

From Independent RSS Feed: Researchers uncover link between weight loss drugs and alcohol intake: ‘Its importance cannot be overstated’

From Independent RSS Feed: Weight loss jabs may help curb alcohol consumption, study finds

Alcoholics given semaglutide reduced alcohol consumption, had fewer heavy drinking days and saw a reduction in alcohol cravings

A rare form of vision loss has been linked to certain GLP-1s, but more so to Wegovy than to other weight-loss drugs in this class. Should you worry?

It'll probably take several years before generic semaglutide could arrive stateside.

The FDA issued a warning letter to Novo Nordisk, the Danish drugmaker behind the diabetes and weight-loss medications Ozempic and Wegovy, over unreported potential side effects.